Published in Nat Biotechnol on January 01, 1999
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol (2002) 4.15
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A (2005) 2.76
Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer (2010) 2.70
Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A (2001) 2.62
Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A (2007) 2.46
Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res (2009) 1.76
Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem (2009) 1.73
MsbA transporter-dependent lipid A 1-dephosphorylation on the periplasmic surface of the inner membrane: topography of francisella novicida LpxE expressed in Escherichia coli. J Biol Chem (2004) 1.73
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A (2005) 1.65
Use of preferentially replicating bacteria for the treatment of cancer. J Clin Invest (2000) 1.63
Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A (2004) 1.63
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif (2009) 1.55
Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect Immun (2007) 1.50
Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria. PLoS Pathog (2006) 1.49
Trg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating. J Control Release (2014) 1.45
Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol (2011) 1.45
Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity. Cell Cycle (2010) 1.41
Purification and mass spectrometry of six lipid A species from the bacterial endosymbiont Rhizobium etli. Demonstration of a conserved distal unit and a variable proximal portion. J Biol Chem (2000) 1.40
Salmonella enterica serovar Typhimurium response involved in attenuation of pathogen intracellular proliferation. Infect Immun (2001) 1.40
Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures. Clin Microbiol Rev (2008) 1.32
Extragenic suppressors of growth defects in msbB Salmonella. J Bacteriol (2001) 1.31
The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism. Infect Immun (2004) 1.25
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br J Cancer (2009) 1.23
Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice. Cell Cycle (2012) 1.22
Can engineered bacteria help control cancer? Proc Natl Acad Sci U S A (2001) 1.22
Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun (2005) 1.17
Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J Immunol (2011) 1.15
In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis. Cancer Gene Ther (2011) 1.15
Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium. J Immunother (2002) 1.14
Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol Ther (2010) 1.12
Polymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB. J Bacteriol (2010) 1.09
Inhibition of Salmonella enterica serovar Typhimurium lipopolysaccharide deacylation by aminoarabinose membrane modification. J Bacteriol (2005) 1.08
pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine. J Bacteriol (2007) 1.04
Motility is critical for effective distribution and accumulation of bacteria in tumor tissue. Integr Biol (Camb) (2011) 1.02
Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection. Infect Immun (2005) 1.01
Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines. Nat Med (2009) 0.99
Mutation of waaN reduces Salmonella enterica serovar Typhimurium-induced enteritis and net secretion of type III secretion system 1-dependent proteins. Infect Immun (2000) 0.99
Bacterial therapies: completing the cancer treatment toolbox. Curr Opin Biotechnol (2008) 0.99
Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent. Mol Ther (2013) 0.99
Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain. Sci Rep (2012) 0.96
Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model. PLoS One (2016) 0.95
New technologies in developing recombinant attenuated Salmonella vaccine vectors. Microb Pathog (2012) 0.95
Bacteria in Cancer Therapy: Renaissance of an Old Concept. Int J Microbiol (2016) 0.95
Genetic Circuits in Salmonella typhimurium. ACS Synth Biol (2012) 0.93
Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications. Mol Cell Proteomics (2011) 0.93
Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha. Appl Environ Microbiol (1999) 0.92
Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors. Mol Ther (2014) 0.90
Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines. Microb Pathog (2007) 0.90
Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours. Br J Cancer (2003) 0.90
Towards a synthetic chloroplast. PLoS One (2011) 0.89
Improved expression systems for regulated expression in Salmonella infecting eukaryotic cells. PLoS One (2011) 0.89
Salmonella enterica serovar Typhimurium expressing mutant lipid A with decreased endotoxicity causes maturation of murine dendritic cells. Infect Immun (2003) 0.89
CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers. J Biol Chem (2013) 0.88
Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri. J Bacteriol (2008) 0.86
Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies. Vaccine (2007) 0.86
Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant. Infect Immun (2011) 0.85
Tumor-targeted delivery of biologically active TRAIL protein. Cancer Gene Ther (2010) 0.85
Salmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactions. Virulence (2012) 0.85
Salmonella typhimurium mediated delivery of Apoptin in human laryngeal cancer. Int J Med Sci (2013) 0.84
Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI. Magn Reson Med (2013) 0.84
An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth. Cancer Gene Ther (2009) 0.84
A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy. Cancer Discov (2012) 0.83
Hot spot for a large deletion in the 18- to 19-centisome region confers a multiple phenotype in Salmonella enterica serovar Typhimurium strain ATCC 14028. J Bacteriol (2004) 0.82
Salmonella overcomes tumor immune tolerance by inhibition of tumor indoleamine 2, 3-dioxygenase 1 expression. Oncotarget (2016) 0.82
Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. J Immunol (2014) 0.82
Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression. PLoS One (2010) 0.81
Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing. BMC Cancer (2010) 0.81
Attenuation of Salmonella enterica Serovar Typhimurium by altering biological functions of murein lipoprotein and lipopolysaccharide. Infect Immun (2005) 0.81
A Salmonella Typhimurium mutant strain capable of RNAi delivery: higher tumor-targeting and lower toxicity. Cancer Biol Ther (2014) 0.80
Adjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model. Oncotarget (2015) 0.80
Infection, inflammation, and cancer. Nat Biotechnol (1999) 0.80
msbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwf. BMC Microbiol (2009) 0.80
Therapeutic efficacy of tumor-targeting Salmonella typhimurium A1-R on human colorectal cancer liver metastasis in orthotopic nude-mouse models. Oncotarget (2015) 0.80
Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment. J Cancer Res Clin Oncol (2013) 0.79
Tumor suppressor gene RBM5 delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverse apoptotic signaling pathways. World J Surg Oncol (2013) 0.78
Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice. Bioeng Bugs (2009) 0.77
Genetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker. Integr Biol (Camb) (2015) 0.77
Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis. Clin Vaccine Immunol (2016) 0.77
Accumulation of single-stranded DNA in Escherichia coli carrying the colicin plasmid pColE3-CA38. Plasmid (2014) 0.77
Obligate anaerobic Salmonella typhimurium strain YB1 treatment on xenograft tumor in immunocompetent mouse model. Oncol Lett (2015) 0.77
Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth. Asian J Androl (2012) 0.76
Synthetic biology: Bacteria synchronized for drug delivery. Nature (2016) 0.76
Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors. J Cancer (2015) 0.76
Construction of Escherichia coli Mutant with Decreased Endotoxic Activity by Modifying Lipid A Structure. Mar Drugs (2015) 0.75
Bacterial Carriers for Glioblastoma Therapy. Mol Ther Oncolytics (2016) 0.75
Radiotherapy combined with an engineered Salmonella typhimurium inhibits tumor growth in a mouse model of colon cancer. Exp Anim (2016) 0.75
Targeted Cancer Therapy Using Engineered Salmonella typhimurium. Chonnam Med J (2016) 0.75
EGFR-targeted Chimeras of Pseudomonas ToxA released into the extracellular milieu by attenuated Salmonella selectively kill tumor cells. Biotechnol Bioeng (2016) 0.75
The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma. Onco Targets Ther (2015) 0.75
A culture-based method for determining the production of secreted protease inhibitors. J Microbiol Methods (2014) 0.75
Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy. Microb Cell Fact (2015) 0.75
Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis. Sci Rep (2016) 0.75
The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009. Oncotarget (2016) 0.75
Chloroquine enhanced the anticancer capacity of VNP20009 by inhibiting autophagy. Sci Rep (2016) 0.75
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nat Commun (2017) 0.75
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
MCML--Monte Carlo modeling of light transport in multi-layered tissues. Comput Methods Programs Biomed (1995) 11.10
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol (1999) 8.21
Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med (1993) 6.88
Endonuclease G is an apoptotic DNase when released from mitochondria. Nature (2001) 6.20
Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature (2013) 5.44
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol (2009) 5.08
PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol (1998) 5.01
Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol (1999) 4.97
Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science (1997) 4.81
Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sci U S A (1992) 4.72
Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol (1993) 4.62
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science (1999) 3.98
A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells. J Bacteriol (1993) 3.91
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science (2000) 3.72
Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect Immun (2000) 3.59
PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol (1996) 3.54
SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet (1998) 3.51
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA (1995) 3.48
Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res (1997) 3.45
Enrichment of gene-coding sequences in maize by genome filtration. Science (2003) 3.41
A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium. Proc Natl Acad Sci U S A (2000) 3.39
Ultrahigh resolution Fourier domain optical coherence tomography. Opt Express (2004) 3.26
Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems. Mol Microbiol (1999) 3.15
PhoP/PhoQ transcriptional repression of Salmonella typhimurium invasion genes: evidence for a role in protein secretion. Mol Microbiol (1995) 3.11
Contribution of Salmonella typhimurium type III secretion components to needle complex formation. Proc Natl Acad Sci U S A (2000) 3.10
Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol (1995) 3.06
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05
Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol (1992) 3.03
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. J Clin Invest (1998) 3.01
Studies of protein-protein interfaces: a statistical analysis of the hydrophobic effect. Protein Sci (1997) 3.00
Salmonella: a model for bacterial pathogenesis. Annu Rev Med (2001) 2.99
Salmonella stimulate macrophage macropinocytosis and persist within spacious phagosomes. J Exp Med (1994) 2.85
A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J Bacteriol (1991) 2.82
Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol (2000) 2.74
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74
Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet (2001) 2.72
A model of intracranial pulsations. Pediatr Neurosurg (2001) 2.67
In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A (2000) 2.67
Salmonella typhimurium secreted invasion determinants are homologous to Shigella Ipa proteins. Mol Microbiol (1995) 2.65
Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J (2000) 2.64
Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis (2000) 2.63
Crystal structure of yeast tRNAAsp. Nature (1980) 2.61
phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis (1996) 2.58
Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol (1995) 2.53
Transcriptional activation of Salmonella typhimurium invasion genes by a member of the phosphorylated response-regulator superfamily. Mol Microbiol (1996) 2.46
Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature (2000) 2.44
Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol (1989) 2.43
The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci U S A (1998) 2.38
Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis. Infect Immun (1995) 2.35
Identification of a putative Salmonella enterica serotype typhimurium host range factor with homology to IpaH and YopM by signature-tagged mutagenesis. Infect Immun (1999) 2.35
Cloning and characterization of a Leishmania gene encoding a RNA spliced leader sequence. Nucleic Acids Res (1986) 2.33
ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab (1996) 2.32
A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J Biol Chem (2000) 2.32
Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J Biol Chem (2001) 2.30
Oxidation of reduced inorganic sulfur compounds by bacteria: emergence of a common mechanism? Appl Environ Microbiol (2001) 2.28
A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol (2000) 2.26
Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron (2000) 2.20
Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A (1998) 2.17
RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines. FASEB J (1993) 2.11
Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology (1972) 2.09
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics (2001) 2.08
A dataset of protein-protein interfaces generated with a sequence-order-independent comparison technique. J Mol Biol (1996) 2.07
A prognostic index for 30-day mortality after stroke. J Clin Epidemiol (2001) 2.07
Complexities in the genetic structure of Anopheles gambiae populations in west Africa as revealed by microsatellite DNA analysis. Proc Natl Acad Sci U S A (1998) 2.06
Small espin: a third actin-bundling protein and potential forked protein ortholog in brush border microvilli. J Cell Biol (1998) 2.06
Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J Biol Chem (1998) 2.06
Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med (2000) 2.05
Predicting readmission to the psychiatric hospital in a managed care environment: implications for quality indicators. Am J Psychiatry (1997) 2.02
The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol (1995) 1.99
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Res (2001) 1.98
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev (1994) 1.97
Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med (2000) 1.97
A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis (2004) 1.96
Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol (1975) 1.93
The future of scattered trees in agricultural landscapes. Conserv Biol (2008) 1.92
Transcriptional regulation of Salmonella virulence: a PhoQ periplasmic domain mutation results in increased net phosphotransfer to PhoP. J Bacteriol (1996) 1.92
Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect (2001) 1.91
Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys (1993) 1.89
Protein binding versus protein folding: the role of hydrophilic bridges in protein associations. J Mol Biol (1997) 1.86
Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J Cell Biol (1998) 1.85
Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. Med Pediatr Oncol (1996) 1.85
On the possibility of coherently stimulated recombination and cosmological structure generation: recombination instability. Proc Natl Acad Sci U S A (1995) 1.84
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. J Natl Cancer Inst (1998) 1.82
The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct (2001) 1.82
Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci. Infect Immun (1994) 1.80
Sexual behaviour and contraceptive use among unmarried, young women migrant workers in five cities in China. Reprod Health Matters (2001) 1.77
Kinetics and pattern of organelle exocytosis during Toxoplasma gondii/host-cell interaction. Parasitol Res (1993) 1.76
A HilA-independent pathway to Salmonella typhimurium invasion gene transcription. J Bacteriol (1999) 1.76
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J (1995) 1.76
Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol (1995) 1.73
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol (1997) 1.72
Prevalence of head and neck cancers in the north east-An institutional study. Indian J Otolaryngol Head Neck Surg (2006) 1.72
Regulation of dental enamel shape and hardness. J Dent Res (2010) 1.71